Publications by authors named "Donald Slaughter"

Claim this Profile
K
Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.
Christopher D Cox, Paul J Coleman, Michael J Breslin, David B Whitman, Robert M Garbaccio, Donald E Slaughter

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
Robert M Garbaccio, Edward S Tasber, Lou Anne Neilson, Paul J Coleman, Mark E Fraley, Donald E Slaughter

Bioorg Med Chem Lett· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.
Christopher D Cox, Maricel Torrent, Michael J Breslin, Brenda J Mariano, David B Whitman, Donald E Slaughter

Bioorg Med Chem Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.
Robert M Garbaccio, Mark E Fraley, Edward S Tasber, Christy M Olson, William F Hoffman, Donald E Slaughter

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme.
Kelem Kassahun, Konstantine Skordos, Ian McIntosh, Donald Slaughter, George A Doss

Chem Res Toxicol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
Ping Lu, Michael L Schrag, Donald E Slaughter, Conrad E Raab, Magang Shou

Drug Metab Dispos· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of rofecoxib in vitro using human liver subcellular fractions.
Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J Walsh

Drug Metab Dispos· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents.
John W Butcher, Nigel J Liverton, David A Claremon, Roger M Freidinger, Nancy K Jurkiewicz, Donald E Slaughter

Bioorg Med Chem Lett· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicine in the Life of François Rabelais (Conclusion).
Donald Slaughter

Ann Med Hist· September 1939

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicine in the Life of François Rabelais.
Donald Slaughter

Ann Med Hist· July 1939

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis